We spend billions of euro each year to identify and develop medicines and vaccines that can help people around the world.
We carry out research across a broad range of therapeutic areas, including heart and lung disease, infectious diseases, vaccines, cancer, neurology and women's health, and new areas such as biologics.
Thanks to the talent and tenacity of our researchers - combined with the scientific and technological advances of the past decade - we are in an exciting period of discovery at MSD as we continue to seek new and innovative ways to improve health.
It takes a long time to identify a potential new treatment. Teams of scientists can screen thousands of molecules to identify a promising lead. Then that has to be refined and tested in clinical trials before we can apply for regulatory approval.
A tiny fraction of the potential treatments that we evaluate ultimately survive the tough process of research, development and testing to finally become medicines.
To learn more about our pipeline of new and innovative medicines click here.